3Birke FW,Meade CJ,Anderskewitz R,et al.In vitro and vivo pharmacological characterization of BⅢ284,A novel and potent leukotriene B4,receptor antagonist[J].Pharmacol Exp Ther,2001,297(7):458-466.
4Crooks SW,Bayley DL,Hill SL,et al.Bronchial inflammation in acute bacterial exacerbations of chronic bronchitis:the role of leukotriene B4[J].Eur Respir J,2000,15(2):274-280.
5Piperno D,Pacheco Y,Hosni R,et al.Increased plasma levels of atrial natriuretic factor,renin activity,and leukotriene C4 in chronic obstructive pulmonary disease[J].Chest,1993,104(2):454-459.
6Mitsunobu F,Mifune T,Hosaki Y,et al.Enhanced production of leukotrienes by peripheral leukocytes and specific IgE antibodies in patients with chronic obstructive pulmonary disease[J].Allergy Clin Immunol,1996,107(3):492-498.
7Ronchi MC,Piragino C,Rosi E,et al.Role of sputum differential cell count in detecting airway inflammation in patients with chronic bronchial asthma or COPD[J].Thorax,1996,51(10):1000-1004.
8Pinar C,Aysin S,Yavuz H,et al.Short-term effects of montelukast in stable patients with moderate to severe COPD[J].Respiratory Medicine,2006,99(7),444-450.
1Szafranski W,Cukier A,Ramirez A,et al. Efficacy and safety of budesonide/formoterol in the management of chronic obstructive pulmonary disease. Eur Respir J, 2003,21 (1): 74-81,
2Barnes P. Scientific rationale for inhaled combination therapy with long-acting β2-agonist and corticosteroids. Eur Respir J,2002,19(1): 182-191.
3Roth M, Johnson PR, Rudiger JJ, et al. Interaction between glucoorticoids and β2-agonist on bronchial airway smooth muscle cell through synchronized cellular signaling. Lancet, 2002,360(9342): 1293-1299.
4Senderovitz T, Vestbo J,Frandsen N,et al. Steroid reversibility test followed by inhaled budesonide or placebo in outpatients with stable chronic obstructive pulmonary disease. The Danish Society of Respiratory Medicine. Respir Med, 1999,93(10):715-718.
5van Grunsven P, van Schayck C, et al. Long term effects of inhaled corticosteroids in chronic obstructive pulmonary disease:a meta analysis. Thorax,1999,54(1):7-14.
6Abdullah A,Sin DD,McAlister FA,et al. The Effects of Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease: A Systematic Review of Randomized Placebo-Controlled Trials.Am J Med,2002,113(1):59-65.
7Highland KB,Stvarge C,Heffaver JE,et al. Long-Term Effects of Inhaled Corticosteroids on FEV1 in Patients with Chronic Obstructive Pulmonary Disease. Ann Intern Med, 2003, 138(12) :969-973.
8Sutherland ER, Allmers H, Ayas NT, et al. Inhaled corticosteroids reduce the progression of airflowlimitation in chronic obstructive pulmonary disease: a meta analysis. Thorax,2003,58(11) :937-941.
9Aidan O′ Brien, Patricia Russo-Magno, et al. Effects of withdrawal of inhaled steroids in men with severe irreversible airflow obstruction. Am J Respir Crit Care Med, 2001,164 (3):365-371.
10Jarad NA,Wedzicha JA,Bnvge DS,et al. An observational study of inhaled corticosteroid withdrawal in stable chronic obstructive pulmonary disease. Respir Med,1999,93(3) :161-166.
